Tracking is what separates a protocol from guesswork
That sentence is the Playbook's own framing of its daily log, and it is the reason Claritide exists as a product rather than a library.
The daily log
One row per day. The columns:
Date · Peptide · Dose · Time · Injection site · Sleep (1–10) · Energy (1–10) · Pain (1–10) · Notes and side effects
Nine fields, most of which take a second. Three subjective scales, all 1–10.
Why those three scales
Sleep, energy and pain are the ones the Playbook prints, and the choice is deliberate.
They are the outcomes most of these compounds actually move. They are things you can rate honestly without equipment. And they are sensitive enough to shift within the timeframe of a cycle, unlike body composition, which moves slowly enough that daily measurement is noise.
A 1–10 scale is crude, and that is a feature. You will not agonise over whether today was a 6 or a 6.5. Consistency of rating matters more than precision, so rate quickly and move on.
The other columns are not filler
Injection site feeds rotation. Without a log you will genuinely forget which zone you used yesterday.
Time matters more than it looks for the compounds where timing is mechanistic: DSIP at 4–6 PM, tesamorelin at bedtime fasted, GHRPs on an empty stomach. If a protocol is not working, the log tells you whether you actually ran it as designed.
Dose matters during escalation phases, and for retrospective analysis when you are trying to work out when something changed.
Notes and side effects is where the real signal usually lives. "Nausea, 4 hours after dose" three times in a week is a pattern. Written down it is obvious; remembered, it is a vague sense that something is off.
What to measure less often
Bodyweight, waist and body fat on a weekly cadence rather than daily. Daily weight is mostly water and produces anxiety rather than information.
Bloodwork at baseline, week 4 and week 8.
Photos for anything visual. GHK-Cu's skin changes and tesamorelin's body composition changes are both hard to perceive day to day and obvious across eight weeks. Same lighting, same pose, same time of day.
Measure the thing the compound actually changes
This is where people go wrong most often.
Tesamorelin reduces visceral fat while increasing lean mass. Total scale weight may barely move. If you evaluate it on the bathroom scale you will conclude it failed, when waist circumference or a DEXA scan would have shown a clear result. The Playbook specifies reassessment by DEXA, CT, or waist and waist-to-hip measurements for exactly this reason.
GHK-Cu produces nothing visible for four weeks. Judging it at week two measures your patience, not the compound.
MOTS-C is a metabolic amplifier, not a stimulant. If you evaluate it by whether you feel a hit, you are measuring the wrong axis.
The honest note
Some of what you log will be placebo. The Playbook says so directly about MOTS-C week one: some report a subtle energy lift within days, and this could be placebo.
Tracking does not eliminate that. What it does is make patterns visible over enough days that a genuine effect separates from an expectation, and it gives you the sample size to say "eighteen nights" rather than "it feels better".